CAS: 30566-92-8 - 5-(N,N-Dibenzylglycyl)salicylamide
Formel:C23H23N2O3
InChl:InChI=1S/C23H22N2O3/c24-23(28)20-13-19(11-12-21(20)26)22(27)16-25(14-17-7-3-1-4-8-17)15-18-9-5-2-6-10-18/h1-13,26H,14-16H2,(H2,24,28)
InChI Key:InChIKey=DNLPQXRWAKCKPX-UHFFFAOYSA-N
SMILES:O=C(N)C1=CC(=CC=C1O)C(=O)CN(CC=2C=CC=CC2)CC=3C=CC=CC3
- Synonyme:
- 5-(N,N-dibenzylglycyl)-2-hydroxybenzamide
- 5-[2-[Bis(phenylmethyl)amino]acetyl]-2-hydroxybenzamide
- Benzamide, 5-[2-[Bis(Phenylmethyl)Amino]Acetyl]-2-Hydroxy-
- Benzamide, 5-[[bis(phenylmethyl)amino]acetyl]-2-hydroxy-
- N,N-dibenzyl-2-(3-carbamoyl-4-hydroxyphenyl)-2-oxoethanaminium
- Salicylamide, 5-(N,N-dibenzylglycyl)-
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Benzamide, 5-[2-[bis(phenylmethyl)amino]acetyl]-2-hydroxy- REF: IN-DA0030K7CAS: 30566-92-8 | - - - | Nachfragen | Di 03 Dez 24 | |
Labetalol Impurity 1 REF: 4Z-L-486CAS: 30566-92-8 | - - - | Nachfragen | Mo 02 Dez 24 | |
5-(N,N-Dibenzylglycyl)-salicylamide REF: 3D-FD147371CAS: 30566-92-8 | Min. 95% | Nachfragen | Di 14 Jan 25 |
Benzamide, 5-[2-[bis(phenylmethyl)amino]acetyl]-2-hydroxy-
Ref: IN-DA0030K7
Unbestimmte Größe | Nachfragen |
Labetalol Impurity 1
Ref: 4Z-L-486
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
5-(N,N-Dibenzylglycyl)-salicylamide
Ref: 3D-FD147371
1mg | Nachfragen | ||
2mg | Nachfragen | ||
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen |